|
FDA Draft Guidance: Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products
|
|
4
|
202
|
January 18, 2026
|
|
Bootstrapped variable selection in the presence of competing risk
|
|
7
|
96
|
January 12, 2026
|
|
The growing interest in integrating causal inference and Design Theory
|
|
7
|
176
|
January 6, 2026
|
|
Should causal modeling be a required part of a NIH grant applications?
|
|
1
|
91
|
December 17, 2025
|
|
Randomized non-comparative trials: an oxymoron?
|
|
73
|
4381
|
December 15, 2025
|
|
Cause-Agnostic RCT (CAR)
|
|
9
|
421
|
December 12, 2025
|
|
A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders – Results from the 2 NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model
|
|
2
|
81
|
December 11, 2025
|
|
MICE Imputation Models
|
|
10
|
397
|
December 6, 2025
|
|
NEJM Trial - proportional hazard assumption
|
|
12
|
332
|
December 1, 2025
|
|
The Design Theory /Causal Inference Divide Explained by the Position of U
|
|
2
|
139
|
November 28, 2025
|
|
Rarity Roulette: A simulator for estimating hypothetical outcomes spreads for mass screenings
|
|
2
|
85
|
November 20, 2025
|
|
Individual response
|
|
266
|
48930
|
November 17, 2025
|
|
When and why (not) to worry about the PO assumption
|
|
4
|
613
|
October 9, 2025
|
|
Comparing multiple groups to a reference group
|
|
7
|
198
|
October 6, 2025
|
|
Bayesian Clinical Trials: Interview with Frank Harrell
|
|
0
|
214
|
September 18, 2025
|
|
Estimating the probability of neonatal sepsis with plug-in incidence
|
|
6
|
130
|
September 11, 2025
|
|
Fine-Gray vs Cause-Specific Cox Regression
|
|
0
|
113
|
September 11, 2025
|
|
Sample Size Calculation for a 2x2 Factorial RCT
|
|
6
|
255
|
September 3, 2025
|
|
Table 2 Fallacy?: Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
|
|
32
|
4240
|
August 12, 2025
|
|
Illogic of Weighting While Estimating Model Parameters
|
|
13
|
799
|
August 11, 2025
|
|
Statistical Process Control and Experimental Design
|
|
9
|
387
|
May 13, 2025
|
|
Challenges in determining meaningful between group differences of surgery vs non-surgical treatment
|
|
12
|
776
|
May 9, 2025
|
|
Why the Non-Reproducibility of Acute Care RCT? The CAP studies
|
|
6
|
196
|
May 8, 2025
|
|
Should I Exclude Patients Based on Treatment Criteria?
|
|
4
|
90
|
April 29, 2025
|
|
Reanalyzing MERIT design using Julia + recent numerical algorithms
|
|
2
|
177
|
April 28, 2025
|
|
Decision analysis calculations
|
|
17
|
434
|
April 27, 2025
|
|
Factorial trial with interest in individual contrasts
|
|
1
|
52
|
April 26, 2025
|
|
CONSORT 2025 RCT standards document
|
|
2
|
187
|
April 25, 2025
|
|
A randomized withdrawal design
|
|
0
|
65
|
April 24, 2025
|
|
Logistic Model Shap Analysis
|
|
6
|
748
|
April 20, 2025
|